ParcelBio raises $13M
ParcelBio announced a Seed round of $13M on 7 May 2026. The company operates in HealthTech and is based in United States. It was founded by David Weinberg, Co-Founder & CEO.
Founder
David Weinberg
Co-Founder & CEO, ParcelBio
Outreach angles
- -David Weinberg holds an MIT PhD, was a UCSF Faculty Fellow, and earned a Forbes 30 Under 30 plus an NIH Early Independence Award.
- -Previously VP of RNA Platform at Orbital Therapeutics/Circ Bio and led multiomics at Freenome where he built the platform behind a blood-based cancer test.
- -$13M seed led by Breyer Capital with Y Combinator and General Catalyst participation to advance the APEXm programmable mRNA platform into in vivo CAR T and oncology programs.
Signals
SeedHealthcareDeep TechYC BackedEx-YCRegulated Industry
Round details
Company: ParcelBio
Domain: parcelbio.com
Amount: $13M
Stage: Seed
Industry: HealthTech
Country: United States
Announced: 7 May 2026
Other HealthTech raises
Recently funded in United States